Uni-Bio Science Group Ltd. is an investment holding company with interests in pharmaceutical research and development. The firm operates through four segments. In-house Chemical Pharmaceutical Products segment is engaged in the manufacture and sales of in-house chemical pharmaceutical products. Its chemical pharmaceutical products include Pinapu, among others. In-house Biological Pharmaceutical Products segment is engaged in the manufacture and sales of in-house biological pharmaceutical products. Its biological pharmaceutical products include GeneTime and GeneSoft, among others. In-house Biological Pipeline segment is engaged in the industrialization of in-house biological pipeline. Its biological pipeline products include Uni-E4 and Uni-PTH, among others. Third-party Pharmaceutical Products segment is engaged in the sales of third-party pharmaceutical products.
Follow-Up Questions
Uni-Bio Science Group Ltd のCEOは誰ですか？
Mr. Zhi Gang Zhao は Uni-Bio Science Group Ltd の Chief Executive Officer で、2014 から在籍しています。
UNBSF の株価パフォーマンスは？
UNBSF の現在の価格は $0 で、最終取引日から 0% decreased 変動しました。
Uni-Bio Science Group Ltd の主な事業テーマや業界は？
Uni-Bio Science Group Ltd は Biotechnology 業界、セクターは Health Care に属しています。
